Drug intelligence / Profile preview

Danshen Gegen

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Danshen Gegen is a traditional Chinese herbal combination consisting of the roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen). It is widely used in Chinese medicine for its cardioprotective and anti-atherosclerotic effects. The formulation has been studied for its ability to reduce the extent of atherosclerosis, protect against myocardial ischemia/reperfusion injury, and modulate early events in atherosclerosis such as macrophage lipid loading and monocyte adhesion to endothelial cells. Mechanistically, it appears to exert antioxidant effects on mitochondria, enhance membrane integrity in cardiac tissue via redox-sensitive protein kinase C-epsilon pathways, inhibit osteoclastogenesis in vitro, relax coronary arteries through vasodilation (attributed mainly to danshen), and modulate inflammatory cell adhesion molecules. Clinical studies suggest potential benefits for coronary heart disease and stroke prevention; however, evidence quality varies. Herb-drug interactions are significant—especially with anticoagulants like warfarin or antiplatelet agents like aspirin—due to effects on drug metabolism and blood clotting parameters[4][5][8][9].

Brand names
Danshen Gegen
Other names
DGDanshen-Gegen decoctionDanshen-Gegen formulaSalvia miltiorrhiza + Pueraria lobata formulation
02

Targets

CXCR4 (C-X-C motif chemokine receptor 4)CYP1A1 (Cytochrome P450 1A1)CYP2B1 (Cytochrome P450 2B1)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)STAT3 (Signal Transducer and Activator of Transcription 3)MPTP (Mitochondrial permeability transition pore)

Beyond the preview

Go deeper on Danshen Gegen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Danshen Gegen.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call